|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.210 USD | -6.63% |
|
-10.94% | -8.11% |
| 01-08 | MannKind provides business updates and 2026 growth drivers | RE |
| 12-23 | MannKind Says FDA Approves Furoscix Autoinjector Use for Pediatric Patients With Fluid Retention | MT |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||||
Pharmaceuticals | 65.14M | 75.44M | 99.77M | 199M | 286M | |||||
Total Assets | 109M | 321M | 295M | 475M | 394M | |||||
Interest Expense | -9.47M | -16.58M | -24.77M | -25.16M | -37.98M | |||||
Income Tax Expense | -218K | - | - | 1.56M | 2.93M | |||||
CAPEX | -4.78M | -11.47M | -7.59M | -42.44M | -9.69M | |||||
EBT | -57.46M | -80.93M | -87.4M | -10.38M | 30.52M | |||||
D&A | 3.06M | 5.1M | 8.68M | 5.84M | 9.04M | |||||
Operating Income | -47.91M | -47.02M | -64.11M | 8.68M | 72.59M | |||||
Net Income | -57.24M | -80.93M | -87.4M | -11.94M | 27.59M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
United States of America | - | 75.44M | 99.77M | 199M | 286M | |||||
Total Assets | - | 321M | 295M | 475M | 394M | |||||
Interest Expense | - | -16.58M | -24.77M | -25.16M | -37.98M | |||||
Income Tax Expense | - | - | - | 1.56M | 2.93M | |||||
D&A | - | 5.1M | 8.68M | 5.84M | 9.04M | |||||
CAPEX | - | -11.47M | -7.59M | -42.44M | -9.69M | |||||
Net Income | - | -80.93M | -87.4M | -11.94M | 27.59M | |||||
EBT | - | -80.93M | -87.4M | -10.38M | 30.52M | |||||
Operating Income | - | -47.02M | -64.11M | 8.68M | 72.59M |
- Stock Market
- Equities
- MNKD Stock
- Financials MannKind Corporation
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition